Many of Australiaâs top brokers have been busy adjusting their financial models again, leading to the release of a number of broker notes this week.
Three ASX shares brokers have named as buys this week are listed below. Hereâs why they are bullish on them:
Core Lithium Ltd (ASX: CXO)
According to a note out of Macquarie, its analysts have retained their outperform rating on this lithium minerâs shares with an improved price target of $1.50. This follows news that the companyâs drilling activities have led to the more than doubling of the Finniss Lithium Project mineral resource estimate. The Core Lithium share price is trading at 96.7 cents this afternoon.
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)
A note out of Goldman Sachs reveals that its analysts have retained their conviction buy rating and $27.00 price target on this medical device companyâs shares. Fisher & Paykel Healthcare remains Goldman’s top pick in the healthcare sector. The broker believes the company is now on the correct side of an earnings inflection cycle. This is being driven predominantly by demand, but importantly compounded by a lower-risk margin recovery profile. The Fisher & Paykel Healthcare share price is fetching $24.31 today.
IGO Ltd (ASX: IGO)
Analysts at Citi have retained their buy rating and $17.10 price target on this battery materials minerâs shares. Although the broker suspects that lithium shares could struggle in the near term due to lithium price weakness, it remains positive on IGO due partly to its attractive valuation. In addition, the broker believes that lithium prices could rebound when industry restocking picks up in the coming months. The IGO share price is trading at $13.38 on Wednesday.
The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
FREE Beginners Investing Guide
Despite what some people may say – we believe investing in shares doesn’t have to be overwhelming or complicated…
For over a decade, we’ve been helping everyday Aussies get started on their journey.
And to help even more people cut through some of the confusion “experts’” seem to want to perpetuate – we’ve created a brand-new “how to” guide.
Yes, Claim my FREE copy!
*Returns as of March 1 2023
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Broker gives its verdict on the Core Lithium share price
- Here are the 3 most heavily traded ASX 200 shares on Monday
- Why Block, BrainChip, Core Lithium, and Life360 shares are racing higher
- Why is the Core Lithium share price soaring 11% today?
- Here are the 10 most shorted ASX shares this week
Motley Fool contributor James Mickleboro has positions in Nextdc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Harvey Norman and Tyro Payments. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool Australia has recommended Tyro Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/bCgMUmu
Stock Pick 